Semaglutide
a GLP-1 receptor agonist
- What it is
- A GLP-1 receptor agonist — it copies a hormone your gut releases after you eat, the signal that tells your brain you're satisfied and helps your body manage blood sugar.
- What it's studied for
- Studied for its effect on appetite signaling, slowed gastric emptying, and blood-sugar regulation. It is among the most-studied molecules in modern metabolic medicine.
- How it's typically delivered
- Typically a once-weekly self-administered injection, started low and titrated upward over time by your provider. The exact dose and schedule are determined by your provider — not by you.
Compounded medications are not FDA-approved. A US-licensed provider decides whether Semaglutide is right for you.
See the GLP-1 Weight Care program